mutations and complicated kar yotype. It follows a linear evolution within the CLL clone with the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding regions with the genome, are largely located in Energetic promoters or enhancers, and modify the binding sites of a variety of transcription as